MORGAN STANLEY - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 96 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$514,284
-16.8%
203,275
+118.9%
0.00%
Q2 2023$618,494
-74.5%
92,867
-28.6%
0.00%
Q1 2023$2,427,461
-9.6%
130,089
+4.1%
0.00%
Q4 2022$2,684,937
-10.8%
124,997
-50.9%
0.00%
Q3 2022$3,011,000
+0.6%
254,742
+12.3%
0.00%
Q2 2022$2,993,000
-32.2%
226,842
+7.5%
0.00%
-100.0%
Q1 2022$4,412,000
-7.5%
211,016
-10.1%
0.00%0.0%
Q4 2021$4,772,000
+30.2%
234,727
+94.4%
0.00%
Q3 2021$3,664,000
+5.7%
120,740
+1.2%
0.00%
Q2 2021$3,466,000
+231.0%
119,262
+391.5%
0.00%
Q1 2021$1,047,000
+1.1%
24,265
+8.1%
0.00%
Q4 2020$1,036,000
+33.3%
22,441
+25.2%
0.00%
Q3 2020$777,000
+100.3%
17,917
+144.9%
0.00%
Q2 2020$388,000
+288.0%
7,315
+63.9%
0.00%
Q1 2020$100,000
-32.9%
4,463
-56.2%
0.00%
Q4 2019$149,000
+684.2%
10,201
+275.9%
0.00%
Q3 2019$19,0002,714
+5800.0%
0.00%
Q2 2019$0
-100.0%
46
-98.1%
0.00%
Q1 2019$24,000
+50.0%
2,470
-40.3%
0.00%
Q4 2018$16,000
-61.0%
4,136
-20.8%
0.00%
Q3 2018$41,000
+272.7%
5,222
+322.2%
0.00%
Q2 2018$11,000
-63.3%
1,237
-57.8%
0.00%
Q1 2018$30,0002,9330.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Logos Global Management LP 430,000$19,866,0001.70%
APIS CAPITAL ADVISORS, LLC 20,000$924,0000.89%
Avidity Partners Management LP 547,000$25,271,0000.82%
Knoll Capital Management, LLC 20,000$924,0000.63%
Artemis Investment Management LLP 1,013,448$46,839,0000.49%
AlphaCentric Advisors LLC 25,000$1,155,0000.48%
First Light Asset Management, LLC 94,202$4,352,0000.32%
Ikarian Capital, LLC 150,000$6,930,0000.31%
Longitude (Cayman) Ltd. 8,000$370,0000.18%
AllSquare Wealth Management LLC 5,490$254,0000.17%
View complete list of BIOXCEL THERAPEUTICS INC shareholders